Table 4:
Species | LA-NCI vs HA-NCI | LA-NCI vs. MCI | LA-NCI vs AD | Overall |
---|---|---|---|---|
NGF mRNA | n.s. | n.s. | n.s. | df=3,95; H = 2.4; p > 0.05 |
NGF protein | rs = 8.842, p = 0.06 | rs = 15.73, p < 0.01 | rs = 17.14, p < 0.01 | df = 2,52; H = 14.38; p < 0.01 |
proNGF 27 kDa | t=4.095, p < 0.001 | t = 7.058, p < 0.001 | t = 4.984 p < 0.001 | df = 3,95; F = 19.96; p < 0.0001 |
proNGF 41 kDa | t = 3.795, p < 0.001 | t = 5.399, p < 0.001 | t = 4.035, p < 0.001 | df = 3,95; F = 12.68; p < 0.0001 |
Plasminogen mRNA | n.s | n.s | n.s | df = 3,95; H = 0.87; p > 0.05 |
Plasminogen protein | t = 2.605, p < 0.05 | t = 4.035, p < 0.001 | t = 3.070 p < 0.01 | df = 3,95; F = 26.80; p < 0.0001 |
tPA mRNA | rs = 22.37, p < 0.05 | n.s | n.s | df = 3,95; H = 7.652; p = 0.05 |
tPA protein | rs = 23.46, p < 0.05 | n.s | n.s | df = 3,95; H = 8.754, p < 0.05 |
Neuroserpin mRNA | n.s | rs = 30.91, p < 0.001 | rs = 22.26, p < 0.05 | df = 3,95; H = 29.23; p < 0.0001 |
Neuroserpin protein | n.s | rs = −34.41, p < 0.001 | rs = −33.39 p < 0.001 | df = 3,95; H = 30.18; p < 0.0001 |
MMP9 mRNA | n.s | rs = 26.67, p < 0.001 | rs = 28.63, p < 0.001 | df = 3,95; H = 25.44; p < 0.0001 |
MMP9 activity | n.s | rs = 27.55, p < 0.001 | rs = 33.91 p < 0.001 | df = 3,95; H = 29.33; p < 0.0001 |
proMMP9 activity | n.s | rs = 27.55, p < 0.001 | t = 33.91 p < 0.001 | df = 3,95; H = 29.33; p < 0.0001 |
TIMP1 mRNA | n.s | rs = 18.90, p < 0.05 | rs = 26.40, p < 0.01 | df = 3,95; H = 15.03; p < 0.01 |
Results of ANOVA/Kruskal-Wallis comparison and Bonferroni/Dunn’s post-hoc tests are reported.